Recce Pharmaceuticals Ltd (ASX: RCE) is pioneering the development and commercialisation of a new class of synthetic antibiotics with broad spectrum activity designed to address the urgent global health problem of antibiotic resistant superbugs.
Bristol-Myers Squibb
291 followers
Astellas Pharma
48 followers
NYU Langone Health
38 followers
West Pharmaceutical Services
11 followers
Curia Global
8 followers
AbbVie
316 followers
Navitus Health
6 followers
Xeris Pharmaceuticals
4 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
7 followers